Marc Fink & Yan Liu & Shangying Wang Student Project Proposal

Slides:



Advertisements
Similar presentations
Mathematical Modelling of Phage Dynamics: Applications in STEC studies Tom Evans.
Advertisements

Modeling of Acute Resistance to the HER2 Inhibitor, Lapatinib, in Breast Cancer Cells Marc Fink & Yan Liu Student Project Proposal Computational Cell Biology.
Bayesian network models of Biological signaling pathways
Student Research Interest HER2 Receptor Signaling in Breast Cancer Cells Marc Y. Fink Biomedical Sciences LIU-Post.
Combined Experimental and Computational Modeling Studies at the Example of ErbB Family Birgit Schoeberl.
Computational biology of cancer cell pathways Modelling of cancer cell function and response to therapy.
P53 Missense Mutation Cancer. Outline Disease related to p53 Role and regulation pathway Structure of p53 Missense mutation and consequences Experiment’s.
Mathematical Modeling of Signal Transduction Pathways Biplab Bose IIT Guwahati.
How to present a scientific paper Dr. Rebecca B. Riggins Department of Oncology, Georgetown University
Specialized signaling pathways 1: RTK associated pathways
Marc Fink & Yan Liu & Shangying Wang Student Project Proposal
The British Computer Society Sidney Michaelson Memorial Lecture 2008 Systems biology: what is the software of life? Professor Muffy Calder, University.
Defining Epidermal Growth Factor Receptor exon 20 mutant sensitivity to tyrosine kinase inhibition Danny Rayes.
Epidermal growth factor receptor tyrosine kinase inhibitors as initial therapy for non- small cell lung cancer: Focus on epidermal growth factor receptor.
Cell Signaling Pathways – A Case Study Approach
PI3K inhibition does not Effect the BH3 Profile of SW620 Cells
Control of Gene Expression
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
In Cardiomyocyte Hypoxia, Insulin-Like Growth Factor-I-Induced Antiapoptotic Signaling Requires Phosphatidylinositol-3-OH-Kinase-Dependent and Mitogen-Activated.
Strategies for differential inhibition of mTORC1 and mTORC2 with rapamycin. Strategies for differential inhibition of mTORC1 and mTORC2 with rapamycin.
Sustaining Proliferative Signaling and Evading Growth Suppressors
Chap. 16 Problem 1 Cytokine receptors and RTKs both form functional dimers on binding of ligand. Ligand binding activates cytosolic kinase domains which.
MAPK pathway inhibitors.
IRS-1: Auditing the effectiveness of mTOR inhibitors
A model for dual inhibition of BCL2 and MCL1 to release BIM and induce apoptosis. A model for dual inhibition of BCL2 and MCL1 to release BIM and induce.
Fas NF-κB JNK Bcl-2 Akt p21 Bax Ras TRAILR p53 EGFR TRADD Myc TNFR
Figure 1 A schematic representation of the HER2 signalling pathway
A FOXO3a-BIM cascade mediates sensitivity to PARP and MEK inhibition
BDNF and insulin signaling pathways activated by phytochemicals.
Schematic representation of main EGFR-TKIs resistance mechanisms.
In-vitro regulation of primordial follicle activation: challenges for fertility preservation strategies  Michael J. Bertoldo, Kirsty A. Walters, William.
Methed-Up FOXOs Can't In-Akt-ivate
Volume 29, Issue 3, Pages (March 2016)
The pathway signalling starts with the binding of insulin or growth factors to insulin receptors. The pathway signalling starts with the binding of insulin.
Development of PI3K/AKT/mTOR Pathway Inhibitors and Their Application in Personalized Therapy for Non–Small-Cell Lung Cancer  Vassiliki Papadimitrakopoulou,
Gonadotropin Signaling in the Ovary
Volume 19, Issue 1, Pages (January 2011)
RAS/RAF pathway-activated ovarian cancer cells exhibit MEK dependence and synergistic induction of apoptosis with combined MEK/AKT inhibition. RAS/RAF.
Volume 96, Issue 5, Pages (March 2009)
IRS-1: Auditing the effectiveness of mTOR inhibitors
How to present a scientific paper
Selective Insulin and Leptin Resistance in Metabolic Disorders
The RAS/MAPK Axis Gets Stressed Out
A New FOXO Pathway Required for Leukemogenesis
Cyclooxygenase-2 in the kidney: good, BAD, or both?
Youry Kim, Jenny L. Anderson, Sharon R. Lewin  Cell Host & Microbe 
SRC and STAT Pathways Journal of Thoracic Oncology
Hilde van Hattum, Herbert Waldmann  Chemistry & Biology 
Rsk1 mediates a MEK–MAP kinase cell survival signal
Mohammadreza Yasemi and Yaman Arkun*
Apoptosis: Current Biology
The nature, significance, and glucagon-like peptide-1 analog treatment of brain insulin resistance in Alzheimer's disease  Konrad Talbot, Hoau-Yan Wang 
Fig. 3. Effects of Tec on IL-1β-induced apoptosis in chondrocytes.
The mitogen-activated protein kinase (MAPK) pathway showing mutations identified in pulmonary Langerhans cell histiocytosis (PLCH). The mitogen-activated.
Friends with Benefits: Microenvironmental NRG1β and HGF Mediate HER2-Targeted Resistance in L-HER2+ and HER2E Breast Cancer  Sarah B. Crist, Cyrus M.
Marijn T.M. van Jaarsveld, Difan Deng, Erik A.C. Wiemer, Zhike Zi 
Signalling pathways and involved entities that are unravelling experimental therapeutic targets for TNBC. Depicted molecular landscape of TNBC confers.
Lesley-Ann Martin, Mitch Dowsett  Cancer Cell 
MiR-200c is a PI3K–AKT signaling pathway regulator in CRC
Potential model of HMQ1611 inhibiting breast cancer cell proliferation
Changes in signal transduction pathway induced by gefitinib.
Schematic representation of signaling pathways associated with cannabinoid receptor activation induced by its agonists. Schematic representation of signaling.
Connections between insulin/insulin-like growth factor 1 signaling and metabolic pathways in tumor cells. Connections between insulin/insulin-like growth.
HER2 and PI3K-targeted therapies result in FOXO3a-mediated feedback upregulation of HER3 and IGF1R and provide an escape from PI3K pathway inhibition.
MTOR kinase inhibition–induced reactivation of AKT substrates is HER2 and PI3K dependent. mTOR kinase inhibition–induced reactivation of AKT substrates.
EPHA2 inhibitors inhibit phosphorylation of AKT and ERK, arrest cell cycle at G0–G1, and induce apoptosis in both vemurafenib (VEM)-sensitive and VEM-resistant.
Inhibition of BCR-mediated signaling by ARQ 531.
Skp2, the FoxO1 hunter Cancer Cell
Tackling Resistance to PI3K Inhibition by Targeting the Epigenome
Presentation transcript:

Analysis of inhibition of HER2 signaling to apoptotic transcription factors Marc Fink & Yan Liu & Shangying Wang Student Project Proposal Computational Cell Biology 2012

Goals Modeling the signaling pathway of HER2 inhibitor, Lapatinib, in Breast Cancer Cells Analyze the influence factors of cell apoptosis Explanation of cell survival rate after treatment

Outline Brief review Boolean network model and results Modeling with ODEs in VCell and COPASI Analysis of simulation results Summary and outlook

Mechanistic (process) diagrams Death Lapatinib ?????? HER2 Survival PI3K PDK1 p AKT (PKB) Protein Translation p ER FoxO p FoxO p 14-3-3 Translocation Translocation Transcription FoxO FoxO Apoptotic genes Apoptosis FoxO FoxO Survival genes 01/13

Flow chart and strategies Lapatinib HER2 IGF1R FASL AKT FoxO apoptosis RAF MEK ERK RSK BAD BIM Lack of experimental parameters => Boolean network Better understanding of dynamics => ODEs Analysis of survival rate => Stochastic simulation 02/13

Boolean network model HER2 AKT FoxO apoptosis BIM Lapatinib IGF1R Apoptosis Time steps => Average value of apoptosis is around 0.5 with simplification. 03/13

Boolean network model HER2 FASL AKT FoxO apoptosis BIM Lapatinib IGF1R Apoptosis Time steps => Average apoptosis is around 0.6 with additional information. 03/13

Boolean network model HER2 FASL AKT FoxO apoptosis RAF MEK ERK RSK BAD BIM Lapatinib IGF1R Apoptosis Time steps => Results depend on the complexity, adding weights not possible. 03/13

Modeling with ODEs => 22 species and 32 reactions, reasonable rates???!!! 04/13

Model reduction and modification Due to the importance of FOXO => Neglect the downstream and add the self regulation 05/13

Model reduction and modification Lapatinib HER2 IGF1R FASL AKT FoxO apoptosis RAF MEK ERK RSK BAD BIM 05/13

Model reduction and modification Due to the importance of FOXO => Neglect the downstream and add the self regulation AKT HER2_dimer HER2_dimer* PI3K H_PI3K PIP2 PIP3 AKT* Lapatinib HER2 AKT FoxO Apoptosis FoxO_gene FoxO_mRNA (x) FoxO (y) FoxO* (z) Φ

Model reduction and modification Due to the importance of FOXO => Neglect the downstream and add the self regulation AKT HER2_dimer HER2_dimer* PI3K H_PI3K PIP2 PIP3 AKT* Lapatinib HER2 AKT FoxO [Birtwistle et al., 2007] Apoptosis FoxO_gene FoxO_mRNA (x) FoxO (y) FoxO* (z) Φ

Self regulation of FOXO FoxO_gene FoxO_mRNA (x) FoxO (y) FoxO* (z) Φ => Bistability of the positive feedback loop 06/13

Modified model => 14 species and 16 reactions 07/13

Sensitivity analysis in COPASI Binding of Laptinib to HER2 Dimerization of HER2 FOXO => Laptinib is important for cancer cell apoptosis 08/13

Analysis of simulation results Deterministic simulations with parameter scan (Laptinib) FOXO concentration With increasing initial Laptinib concentration 0 -> 400 nM 09/13

Analysis of simulation results Deterministic simulations with parameter scan (Laptinib) Phosphorylation => Laptinib is able to stimulate FOXO, crucial to apoptosis 09/13

Analysis of simulation results Random initial concentrations and constant Laptinib (200nM) FOXO concentration => Initial concentrations influence the effect of Laptinib. 10/13

Analysis of simulation results Stochastic simulation using Gillespie algorithm (in VCell & C) High Laptinib Low Laptinib 11/13

Summary and outlook Inhibition of HER2 signaling to apoptotic transcription factors is studied. Models with different complexities are analyzed. Laptinib induced inhibition of HER2 is simulated. Outlook Improve the stochastic study Improve the pathway model with more details by getting more rates from experiments Measurement of concentrations within small time scale before and after treatment will help to understand the whole signaling process and validate the model. 12/13

Experience with the softwares COPASI vs VCell Writing reactions + +++ Checking parameters + +++ Deterministic simulation +++ + Stochastic simulation ++ + Parameter scan +++ ++ Sensitivity analysis +++ - Visualization - +++ 13/13

Happy Birthday to Nina!